Pediatrics HOT COVID-19 Database in NY Tristate
NCT04445402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77
Last updated 2023-05-03
Summary
New York City (NYC) has become the epicenter of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). By collecting and summarizing the experience with other major health care providers in the tristate (New York (NY), New Jersey (NJ) and Connecticut (CT)) are, the investigators are uniquely positioned to inform the rest of the country about what to expect and how to manage children and young adults with hematological, oncological or stem cell transplant diagnoses during the pandemic.
Conditions
- Pediatric Cancer
- Immune System Disorder
- COVID-19
- Hemoglobinopathies
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Prakash Satwani, MD · Columbia University
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-30
- Primary Completion
- 2022-09-12
- Completion
- 2022-09-12
Countries
- United States
Study Locations
More Related Trials
-
Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala
NCT05314816 ·Status: COMPLETED ·Phase: NA
-
The CHILD Cohort COVID-19 Add-On Study
NCT05234359 ·Status: COMPLETED
-
Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique
NCT02000635 ·Status: UNKNOWN
-
Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department
NCT04583189 ·Status: COMPLETED ·Phase: NA
-
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
NCT04588363 ·Status: COMPLETED
-
Febrile Infants Swedish Study
NCT07134751 ·Status: RECRUITING
-
Paediatric European Group A Streptococcal United Study.
NCT06058117 ·Status: RECRUITING
-
CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools
NCT06640387 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Newborns Presenting With Suspected COVID 19
NCT04519307 ·Status: UNKNOWN
-
Pediatric Infectious Disease Precision Medicine Using Sequencing Evaluation of CSF
NCT03796546 ·Status: COMPLETED
-
Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children
NCT04318431 ·Status: COMPLETED ·Phase: NA
-
Host RNA Profiles to Detect Infections in Young Infants
NCT04823026 ·Status: COMPLETED
-
SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
NCT04581148 ·Status: UNKNOWN
-
Invasive Group A Streptococcal Infection
NCT05788861 ·Status: RECRUITING
-
Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France
NCT04336761 ·Status: COMPLETED
-
Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric Department
NCT02325102 ·Status: COMPLETED
-
SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients
NCT04615000 ·Status: COMPLETED
-
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
NCT01441206 ·Status: TERMINATED ·Phase: PHASE1
-
Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.
NCT06618989 ·Status: RECRUITING
-
Respiratory Syncytial Virus Infection May be More Dangerous in Neonate
NCT04531735 ·Status: UNKNOWN
-
Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source
NCT00692848 ·Status: COMPLETED ·Phase: NA
-
Severe Group A Streptococcus Infections in Paris, France, 2018-2023
NCT06297122 ·Status: COMPLETED
-
Safety of Cotrimoxazole in HIV- and HAART-exposed Infants
NCT01086878 ·Status: COMPLETED ·Phase: PHASE4
-
Molecular Culture for the Diagnosis of Pediatric Sepsis
NCT06018792 ·Status: RECRUITING
-
TARGet Kids! COVID-19 Study of Children and Families
NCT04449978 ·Status: COMPLETED